Makris D - Search Results

1

New insights into weaning from mechanical ventilation: left ventricular diastolic dysfunction is a key player.

Papanikolaou J, Makris D, Saranteas T, Karakitsos D, Zintzaras E, Karabinis A, Kostopanagiotou G, Zakynthinos E. Papanikolaou J, et al. Among authors: makris d. Intensive Care Med. 2011 Dec;37(12):1976-85. doi: 10.1007/s00134-011-2368-0. Epub 2011 Oct 6. Intensive Care Med. 2011. PMID: 21976188

2

Statins in bacteremia, sepsis and pneumonia: have we found the holy grail?

Stamatogiannis N, Makris D, Zakynthinos E. Stamatogiannis N, et al. Among authors: makris d. Recent Pat Inflamm Allergy Drug Discov. 2009 Nov;3(3):167-76. doi: 10.2174/187221309789257469. Recent Pat Inflamm Allergy Drug Discov. 2009. PMID: 19663775 Review.

3

Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial.

Keranis E, Makris D, Rodopoulou P, Martinou H, Papamakarios G, Daniil Z, Zintzaras E, Gourgoulianis KI. Keranis E, et al. Among authors: makris d. Eur Respir J. 2010 Oct;36(4):774-80. doi: 10.1183/09031936.00113809. Epub 2010 Feb 11. Eur Respir J. 2010. PMID: 20150206 Free article. Clinical Trial.

4

Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.

Zakynthinos E, Daniil Z, Papanikolaou J, Makris D. Zakynthinos E, et al. Among authors: makris d. Curr Drug Targets. 2011 Apr;12(4):501-13. doi: 10.2174/138945011794751483. Curr Drug Targets. 2011. PMID: 21194405 Review.

5

Current drug targets for the critically ill COPD patient.

Makris D, Zakynthinos E. Makris D, et al. Curr Drug Targets. 2011 Apr;12(4):447-9. doi: 10.2174/138945011794751564. Curr Drug Targets. 2011. PMID: 21194410 No abstract available.

6

The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia.

Makris D, Desrousseaux B, Zakynthinos E, Durocher A, Nseir S. Makris D, et al. Respir Med. 2011 Jul;105(7):1022-9. doi: 10.1016/j.rmed.2011.03.001. Epub 2011 Mar 24. Respir Med. 2011. PMID: 21435855 Free article.

7

Sepsis-associated takotsubo cardiomyopathy can be reversed with levosimendan.

Karvouniaris M, Papanikolaou J, Makris D, Zakynthinos E. Karvouniaris M, et al. Among authors: makris d. Am J Emerg Med. 2012 Jun;30(5):832.e5-7. doi: 10.1016/j.ajem.2011.02.030. Epub 2011 Apr 29. Am J Emerg Med. 2012. PMID: 21530136

8

Adjunctive therapies in severe pneumonia in critical care patients.

Tzovaras N, Karvouniaris M, Makris D, Zakynthinos E. Tzovaras N, et al. Among authors: makris d. Infect Disord Drug Targets. 2011 Aug;11(4):395-400. doi: 10.2174/187152611796504863. Infect Disord Drug Targets. 2011. PMID: 21679141 Review.

9

Nosocomial MRSA pneumonia: data from recent clinical trials.

Karvouniaris M, Makris D, Karabekos D, Zakynthinos E. Karvouniaris M, et al. Among authors: makris d. Rev Recent Clin Trials. 2011 Sep;6(3):235-40. doi: 10.2174/157488711796575568. Rev Recent Clin Trials. 2011. PMID: 21682676 Review.

10

Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study.

Makris D, Manoulakas E, Komnos A, Papakrivou E, Tzovaras N, Hovas A, Zintzaras E, Zakynthinos E. Makris D, et al. Crit Care Med. 2011 Nov;39(11):2440-6. doi: 10.1097/CCM.0b013e318225742c. Crit Care Med. 2011. PMID: 21725239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters